Double trouble: IRAK1/4 inhibitors in AML/MDS

被引：0
|
作者：
Uckelmann, Hannah J. [1 ,2 ,3 ]
Klusmann, Jan-Henning [1 ,2 ,3 ]
机构：
[1] Goethe Univ Frankfurt, Frankfurt, Germany
[2] Frankfurt Canc Inst, Frankfurt, Germany
[3] German Canc Consortium, Dresden, Germany
来源：
BLOOD | 2023年 / 142卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：945 / 946
页数：2
相关论文
共 50 条
  • [31] Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies
    Li, Zhaoyang
    Younger, Kenisha
    Gartenhaus, Ronald
    Joseph, Ann Mary
    Hu, Fang
    Baer, Maria R.
    Brown, Patrick
    Davila, Eduardo
    JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (03): : 1081 - 1097
  • [32] IRAK1/4-Targeted Anti-Inflammatory Action of Caffeic Acid
    Yang, Woo Seok
    Jeong, Deok
    Yi, Young-Su
    Park, Jae Gwang
    Seo, Hyohyun
    Moh, Sang Hyun
    Hong, Sungyoul
    Cho, Jae Youl
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [33] Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by IRAK1 and IRAK4
    Smith, Hilary
    Peggie, Mark
    Campbell, David G.
    Vandermoere, Franck
    Carrick, Emma
    Cohen, Philip
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (12) : 4584 - 4590
  • [34] Upregulated IRAK1 and IRAK4 promoting the production of IFN- and IL-17 in Behcet's disease
    Sun, Min
    Yang, Peizeng
    Yang, Yan
    Ye, Jian
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (05) : 1947 - 1953
  • [35] IRAK1 and IRAK4 Promote Phosphorylation, Ubiquitination, and Degradation of MyD88 Adaptor-like (Mal)
    Dunne, Aisling
    Carpenter, Susan
    Brikos, Constantinos
    Gray, Pearl
    Strelow, Astrid
    Wesche, Holger
    Morrice, Nick
    O'Neill, Luke A. J.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (24) : 18276 - 18282
  • [36] Upregulated IRAK1 and IRAK4 promoting the production of IFN-γ and IL-17 in Behcet’s disease
    Min Sun
    Peizeng Yang
    Yan Yang
    Jian Ye
    International Ophthalmology, 2018, 38 : 1947 - 1953
  • [37] Pivotal Advance:: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
    Loiarro, Maria
    Capolunghi, Federica
    Fanto, Nicola
    Gallo, Grazia
    Campo, Silvia
    Arseni, Brunilde
    Carsetti, Rita
    Carminati, Paolo
    De Santis, Rita
    Ruggiero, Vito
    Sette, Claudio
    JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (04) : 801 - 810
  • [38] IRAK1/4-NFkB-PDL1 axis is important for maintenance of CML-LSCs
    Tanaka, Yosuke
    Goyama, Susumu
    Kitamura, Toshio
    CANCER SCIENCE, 2021, 112 : 364 - 364
  • [39] Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells
    Kawamura, Yoshifumi
    Saijo, Ken
    Imai, Hiroo
    Ishioka, Chikashi
    CANCER SCIENCE, 2021, 112 (11) : 4711 - 4721
  • [40] IRAK1 is a critical mediator of hyaluronic acid induced stemness
    Standing, David
    Dandawate, Prasad
    Johnson, Jaimie
    Gunewardena, Sumedha
    Pritchard, Michele T.
    Pathak, Harsh
    Khabele, Dineo
    Roby, Katherine
    Godwin, Andrew
    Jensen, Roy
    Weir, Scott
    Anant, Shrikant
    CANCER RESEARCH, 2023, 83 (07)
12345